Free Trial

Rhythm Pharmaceuticals (RYTM) SEC Filings & 10K Form

Rhythm Pharmaceuticals logo
$86.70 -2.34 (-2.63%)
Closing price 04:00 PM Eastern
Extended Trading
$88.35 +1.65 (+1.90%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rhythm Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/09/2025
4:06 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
07/09/2025
3:39 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:30 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
4:12 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:55 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
3:56 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:41 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:45 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:45 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:33 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:37 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:48 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:49 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:51 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:52 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:53 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:53 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:50 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:45 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:21 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
3:25 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2025
3:16 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:16 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:27 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2025
3:35 PM
Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
5:20 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/07/2025
6:01 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2025
7:59 AM
BlackRock, Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/16/2025
3:30 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
4:16 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
4:17 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:01 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
4:47 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
8:16 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:21 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
7:19 AM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2025
7:21 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
6:02 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
8:45 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
02/19/2025
8:46 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:47 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:48 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:49 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:50 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:44 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:43 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:36 PM
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
8:46 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:47 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:44 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:45 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:30 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/07/2025
4:05 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:20 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
8:27 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
8:22 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
8:23 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
8:25 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
8:26 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:17 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
8:01 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4/A
11/13/2024
8:02 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
8:04 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:07 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
7:20 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:02 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:49 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:42 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:31 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:32 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:31 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:31 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:31 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:26 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:27 PM
Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:27 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:45 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:13 PM
Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
5:00 AM
Rhythm Pharmaceuticals (Filer)
Form DEFR14A
08/07/2024
5:03 AM
Rhythm Pharmaceuticals (Filer)
Form DEFA14A
08/06/2024
6:00 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:09 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:59 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:30 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
07/16/2024
3:37 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:34 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
4:00 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
4:01 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 424B7
07/10/2024
3:07 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RYTM) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners